Home » Biotronik Enrolls First Patient in Drug-Eluting Balloon Therapy Clinical Study
Biotronik Enrolls First Patient in Drug-Eluting Balloon Therapy Clinical Study
Biotronik AG, a European manufacturer of therapy solutions for vascular intervention, announced the first enrollment in the BIOLUX P-I clinical study.
Euroinvestor
Euroinvestor
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May